JUL 07, 2016 07:32 AM PDT

Genetic Profile of Myeloma Includes 8 New Variants

WRITTEN BY: Xuan Pham
When the Human Genome Project was completed in April 2003, scientists around the world rejoiced in the vast amount of data now at their fingertips. The idea being that if they scrutinized the reference genome extensively, they may be able to find all the disease-causing mutations that plague us all. And in many ways, scientists have done just this – reporting on many mutations that otherwise would have gone unknown for who knows how long.  

Now, using this same approach, scientists at The Institute of Cancer Research (ICR), London announced the discovery of 8 new genetic variations in the human genome that’s linked to myeloma predisposition.

New genetic findings help explain inherited predisposition to myeloma | Image: theusbport.com

"Our study expands our understanding of how inherited risk factors can influence the risk of myeloma. We know that the inherited risk of myeloma does not come from just one or two major risk genes, as can be the case with breast cancer, but from multiple different genetic variants, each with only a small individual effect on risk. Identifying more of these variants gives us new insights into the potential causes of the disease, and open up new strategies for prevention," said Richard Houlston, professor at the ICR, and senior study author.

Myeloma is a rare type of cancer that affects the plasma, or white blood cells. It begins in the bone marrow and affects the immune system’s ability to respond to infections and inflammation. The mutated plasma cells can also lead to high levels of protein in the blood and urine, causing kidney damage. More than 90 percent of myeloma cases are typed as Multiple Myeloma, which means that the cancer affects several different areas of the body.

The causes of myeloma are not yet fully known, though doctors have observed that some people tend to have a higher risk for developing the cancer. These include environmental exposure to carcinogens such as pesticides and fertilizers, and lifestyle choices that affect weight and obesity. Now, the study at the UK adds critical genetic mutations that influences myeloma risks.
 


The team compared DNA from over 9,800 myeloma patients to DNA from over 239,000 healthy adults. This is the largest study of its kind, made possible by a genome-wide association study with data from previous research.

They found 8 base-pair mismatches – single nucleotide polymorphisms (SNPs) – that increased the risk for myeloma. Expectedly, the mutations appear to alter the cellular components involved in plasma cell development, leading to faulty activity and maturation of these cells. 

"These findings give an insight into the genetic and biological basis of why myeloma can occasionally run in families. It is important to remember that while relatives of patients may have a higher risk of developing myeloma than the rest of the population, their absolute risk is still low. Further studies could help guide the development of new drugs to treat this cancer in the future. With a more complete genetic picture, it may even be possible to identify those family members at an increased risk and find ways to prevent them from developing myeloma," said Alasdair Rankin, Research Director at Bloodwise.

Of note, the team estimated that the risk variants they identified only account for just 20 percent of the genetic risk factors for myeloma. That means we still don’t know the other 80 percent of the genetic causes of this disease.

"This research allows us to build a greater understanding of the genetics of myeloma and it could play a vital role in the future development of preventative and curative strategies. It is important to note, however, that myeloma accounts for only 2% of all cancers, so whilst this research takes an extremely important look at the familial risk of developing myeloma, the overall risk to the general populace of developing myeloma is small,” said Eric Low, Chief Executive of the Myeloma UK.

Additional sources: Leukemia & Lymphoma Society, MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 24, 2018
Cancer
JUL 24, 2018
FDA Approves New Drug for Refractory/Relapsed AML
A new drug and new drug class have been approved by the FDA for relapsed or refractory AML patients with an IDH1 mutation. The new drug offers options for patients....
JUL 26, 2018
Genetics & Genomics
JUL 26, 2018
When a Cancer Gene Switches Sides
All cells carry a gene named p53, which has a vital role in shielding the body from cancer. But it can betray cells too....
OCT 07, 2018
Videos
OCT 07, 2018
Certain Foods Encourage a Gut Microbe, and Colon Cancer
Researchers reveal more evidence that refined grains and sugars and processed meats are bad for colon health....
OCT 21, 2018
Technology
OCT 21, 2018
New Technology Detects Early-Stage Lung Cancer
According to recent research published in the Journal of Molecular Diagnostics, outcomes of patients with non-small-cell lung carcinoma (NSCLC) may be impr...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Making Cancer Disappear?
Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is fre...
DEC 05, 2018
Cancer
DEC 05, 2018
Zika virus as a weapon against brain cancer
Glioblastoma is the most aggressive type of Brain Cancer with an average survival rate of less than two years with treatment. So what if there could be a cure for this type of cancer....
Loading Comments...